Posts Categorized: MS News

Source BBC: More than 50,000 disabled people have had specially adapted vehicles taken away since changes to disability benefits in 2013. Read moreabout Thousands have disability vehicles taken away

Source Multiple Sclerosis News Today: British scientists have accelerated from weeks to days the process by which stem cells generate brain cells, which could open the door to new treatment approaches for diseases such as multiple sclerosis. Read moreabout Scientists Accelerate Stem Cells’ Production of Brain Cells to Just Days, Study Reports

Source MS Society: A second independent review into how Personal Independence Payment (PIP) is working was published recently. Read moreabout Missed opportunities in latest PIP review

Source Multiple Sclerosis News Today: Brain stem cells from primary progressive multiple sclerosis (PPMS) patients lack the ability to repair brain damage and to trigger the maturation of protective myelin-producing cells, a surprising study with far-reaching implications indicates. Read more about Research on Faulty Stem Cells Suggests MS Patients Need Tailored Therapies

Read Multiple Sclerosis News Today’s full, ongoing coverage of the Ocrevus approval: News: FDA Approves Ocrevus as 1st MS Treatment for Both Relapsing and Primary Progressive Forms Ocrevus’ Journey from Defiant Idea to Game-Changing Treatment Ocrevus and the Hope of ‘Ending MS Forever’: Interview with MS Society’s Tim Coetzee Social Media: 5 Things to Know… Read more »

  Source MS Trust: Relaxation techniques are activities that generate a feeling of complete peace and calm, away from daily hassles and routines. Read moreabout Relaxation

  Europe’s largest test-drive and independent mobility event. 1 – 3rd June 2017 NAEX Stoneleigh, Warickshire. Free addmission and parking. Fully accessible. Test drive and compare the latest: Accessible vehicles, adapted driving controls, mobility scooters, ramps, wheelchairs, hoists and innovative ideas for easier mobility and much more! Visit their website here.

  Source MS Society: Ocrelizumab has been approved as a treatment for both relapsing and primary progressive MS in the US. https://www.mssociety.org.uk/ms-news/2017/03/first-treatment-licensed-primary-progressive-ms-us

 Source Multiple Sclerosis News Today: The potential approval of Ocrevus (ocrelizumab) this month supports the idea that, someday, a world free of multiple sclerosis (MS) is possible, according to Dr. Tim Coetzee, the National Multiple Sclerosis Society’s chief advocacy, services and research officer. While Coetzee — and the society he represents — realize the potential… Read more »

Source MS Trust: These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story. Please note that the MS Trust did not write the original items and does not endorse their content nor any… Read more »